Evidence map›Paper›PMID 30996264›Full record

ArticleNature communications2019

The Stat3-Fam3a axis promotes muscle stem cell myogenic lineage progression by inducing mitochondrial respiration.

David Sala, Thomas J Cunningham, Michael J Stec, Usue Etxaniz, Chiara Nicoletti, Alessandra Dall'Agnese, Pier Lorenzo Puri, Gregg Duester, Lucia Latella, Alessandra Sacco

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 72 citations in OpenAlex.

  1. FAM3A Inhibits Plasma Triglyceride Levels via Microvasculature-Involved Enhancement of VLDL-Triglyceride Hydrolysis and Lipid Uptake.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Muscle Disuse Atrophy.Advances in experimental medicine and biology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

David SalaDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.
Thomas J CunninghamDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.
Michael J StecDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.
Usue EtxanizDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0002-9961-404X
Chiara NicolettiDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0002-0872-6506
Alessandra Dall'AgneseDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.
Pier Lorenzo PuriDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0003-4964-0095
Gregg DuesterDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0003-4335-3650
Lucia LatellaIRCCS, Fondazione Santa Lucia, Rome, 00142, Italy.
Alessandra SaccoDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, 10901N Torrey Pines Road, La Jolla, CA, 92037, USA. asacco@sbpdiscovery.org.
Sanford Burnham Prebys Medical Discovery Institute · USIstituto di Farmacologia Traslazionale · IT

Funding

Pathogenic Alterations of the 3D Epigenetic Landscape in Dystrophin-Deficient Skeletal Muscles and Reversal by Dystrophin Re-ExpressionR01AR056712 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Pier Lorenzo Puri · 2009 to 2026
$7.3M
Signal-dependent switch of SWI/SNF by miRNAs & control of muscle stem cell fateR01AR052779 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PURI, PIER LORENZO · 2006 to 2015
$4.1M
San Diego Skeletal Muscle Research CenterP30AR061303 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIEBER, RICHARD L. · 2011 to 2015
$3.3M
Factors Regulating Development of Appendicular Skeletal ProgenitorsR01AR067731 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI DUESTER, GREGG L · 2015 to 2019
$2.1M
Role of STAT3 in muscle stem cell activationR01AR064873 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SACCO, ALESSANDRA · 2014 to 2018
$2.1M
Role of STAT3 signaling in muscle stem cell activationR03AR063328 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SACCO, ALESSANDRA · 2013 to 2015
$293k
Exploring the role of Fbxw7 in regulating satellite cell function and skeletal muscle regenerationF32AR070630 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI STEC, MICHAEL JOHN · 2017 to 2018
$106k
NIAMS NIH HHS F32 AR070630NIAMS NIH HHS P30 AR061303NIAMS NIH HHS R01 AR052779NIAMS NIH HHS R01 AR056712NIAMS NIH HHS R01 AR064873NIAMS NIH HHS R01 AR067731NIAMS NIH HHS R03 AR063328
6 · The paper itself

Abstract

Metabolic reprogramming is an active regulator of stem cell fate choices, and successful stem cell differentiation in different compartments requires the induction of oxidative phosphorylation. However, the mechanisms that promote mitochondrial respiration during stem cell differentiation are poorly understood. Here we demonstrate that Stat3 promotes muscle stem cell myogenic lineage progression by stimulating mitochondrial respiration in mice. We identify Fam3a, a cytokine-like protein, as a major Stat3 downstream effector in muscle stem cells. We demonstrate that Fam3a is required for muscle stem cell commitment and skeletal muscle development. We show that myogenic cells secrete Fam3a, and exposure of Stat3-ablated muscle stem cells to recombinant Fam3a in vitro and in vivo rescues their defects in mitochondrial respiration and myogenic commitment. Together, these findings indicate that Fam3a is a Stat3-regulated secreted factor that promotes muscle stem cell oxidative metabolism and differentiation, and suggests that Fam3a is a potential tool to modulate cell fate choices.

Indexed as

Cell DifferentiationAnimalsAnimals, NewbornCell LineageCells, CulturedCytokinesEmbryo, MammalianMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaMuscle DevelopmentMuscle, StriatedMyoblastsOxidative PhosphorylationCytokinesFAM3A protein, mouseStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID30996264
PMCPMC6470137
OpenAlexW2936314700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.